147 related articles for article (PubMed ID: 11249965)
1. Administration of myr(+)-G(i2)alpha subunits prevents acute tolerance (tachyphylaxis) to mu-opioid effects in mice.
Garzón J; Sánchez-Blázquez P
Neuropharmacology; 2001 Mar; 40(4):560-9. PubMed ID: 11249965
[TBL] [Abstract][Full Text] [Related]
2. RGS9 proteins facilitate acute tolerance to mu-opioid effects.
Garzón J; Rodríguez-Díaz M; López-Fando A; Sánchez-Blázquez P
Eur J Neurosci; 2001 Feb; 13(4):801-11. PubMed ID: 11207815
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain.
Garzón J; Rodríguez-Díaz M; López-Fando A; García-España A; Sánchez-Blázquez P
Neuropharmacology; 2002 May; 42(6):813-28. PubMed ID: 12015208
[TBL] [Abstract][Full Text] [Related]
4. RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance.
Garzón J; Rodríguez-Muñoz M; López-Fando A; García-España A; Sánchez-Blázquez P
Neuropsychopharmacology; 2004 Jun; 29(6):1091-104. PubMed ID: 14997173
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
6. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
9. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
[TBL] [Abstract][Full Text] [Related]
10. Hypertolerance to morphine in G(z alpha)-deficient mice.
Hendry IA; Kelleher KL; Bartlett SE; Leck KJ; Reynolds AJ; Heydon K; Mellick A; Megirian D; Matthaei KI
Brain Res; 2000 Jul; 870(1-2):10-9. PubMed ID: 10869496
[TBL] [Abstract][Full Text] [Related]
11. Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia.
Sánchez-Blázquez P; Gómez-Serranillos P; Garzón J
Brain Res Bull; 2001 Jan; 54(2):229-35. PubMed ID: 11275413
[TBL] [Abstract][Full Text] [Related]
12. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
Negri L; Lattanzi R; Melchiorri P
Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
[TBL] [Abstract][Full Text] [Related]
13. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
14. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
15. Role of the guanine nucleotide binding protein, Gα
Lamberts JT; Rosenthal LD; Jutkiewicz EM; Traynor JR
Psychopharmacology (Berl); 2018 Jan; 235(1):71-82. PubMed ID: 28971229
[TBL] [Abstract][Full Text] [Related]
16. Further characterization of alpha N-acetyl beta-endorphin-(1-31) regulatory activity, I: Effect on opioid- and alpha 2-mediated supraspinal antinociception in mice.
Sánchez-Blázquez P; Garzón J
Life Sci; 1992; 50(26):2083-97. PubMed ID: 1318989
[TBL] [Abstract][Full Text] [Related]
17. RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Montero C; Garzón J
Neuropharmacology; 2005 Jan; 48(1):134-50. PubMed ID: 15617734
[TBL] [Abstract][Full Text] [Related]
18. A novel Gbetagamma-subunit inhibitor selectively modulates mu-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence.
Mathews JL; Smrcka AV; Bidlack JM
J Neurosci; 2008 Nov; 28(47):12183-9. PubMed ID: 19020012
[TBL] [Abstract][Full Text] [Related]
19. Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence.
Wang Z; Bilsky EJ; Porreca F; Sadée W
Life Sci; 1994; 54(20):PL339-50. PubMed ID: 7514710
[TBL] [Abstract][Full Text] [Related]
20. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
Sánchez-Blázquez P; García-España A; Garzón J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
